Table 8 Hepatitis A IgG, hepatitis B sAg, hepatitis B cAb and hepatitis b sAb results from 2018 attendees, analysed by their date of first clinic attendance—sub-analysis
From: Changing demographics and immunity to vaccine preventable diseases in people with HIV in Ireland
Variables | Positive | % | Negative | % | Total | P value |
|---|---|---|---|---|---|---|
Hepatitis A IgG | ||||||
First attendance 1987–2013 | 1188 | 88 | 168 | 12 | 1356 | |
First attendance 2014–2018 | 618 | 66 | 320 | 34 | 938 | < 0.001 |
Hepatitis B sAg | ||||||
First attendance 1987–2013 | 46 | 4 | 1135 | 96 | 1181 | |
First attendance 2014–2018 | 17 | 2 | 924 | 98 | 941 | 0.026 |
Hepatitis B cAb | ||||||
First attendance 1987–2013 | 381 | 39 | 584 | 61 | 965 | |
First attendance 2014–2018 | 229 | 25 | 685 | 75 | 914 | < 0.001 |
Hepatitis B sAb | ≥ 10mIU | % | < 10mIU | % | Total | |
First attendance 1987–2013 | 957 | 65 | 525 | 35 | 1482 | |
First attendance 2014–2018 | 544 | 62 | 337 | 38 | 881 | 0.167 |